5:03 PM
 | 
May 08, 2014
 |  BC Extra  |  Financial News

Regeneron's 1Q14 earnings top Street

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported 1Q14 financial results that beat the Street and reaffirmed full-year sales guidance for ophthalmic drug Eylea aflibercept. Non-GAAP...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >